Company intelligence / Profile preview

CRRI

San Diego, California, United Statescrridom.gov.in ↗

Ownership: Private
Development stage: Other

Overview

Crinetics has advanced its lead candidate paltusotine into late-stage clinical trials for acromegaly and carcinoid syndrome. Other programs are in various stages from discovery through early clinical development, targeting rare endocrine diseases with high unmet need

Therapeutic areas: OncologyEndocrinologyNephrology
Modalities: Small moleculeNon-peptide drug conjugateRadiopharmaceutical
Industry: Biotech

Beyond the preview

Go deeper on CRRI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CRRI.

Explore the full profile